Skip to main content
Tweets by JFPS 2020 Virtual Meeting & Exposition
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Personalizing Your Approach With Treatment Options for mNSCLC and R/M HNSCC
Friday, November 13, 2020
12:00 – 13:00 EST
Merck & Company, Inc.
Maxwell C. McDonald, MD
Understand clinical data associated with certain first-line treatment options for mNSCLC
Understand the challenges of treating patients with R/M HNSCC
Review the safety profile and selected adverse events
Presentation Link: https://webinars.on24.com/merck/oncologymeded1